We are actively monitoring the debates of the World Health Assembly as it meets on 21 to 26 May and note the flurry of preparatory consultations involving the Member States and, separately, NGOs, and again separately, private sector representatives. There are numerous important policy issues on the agenda, including preparations on implementation of commitments to address non-communicable diseases, pandemic influenza preparedness and the International Health Regulations, as well as proposals for a new mechanism on “substandard / spurious / falsified / falsely-labeled / counterfeit medical products, an R&D treaty on funding research for neglected diseases and comprehensive organizational reform. This latter includes WHO’s renewed effort to revive and update the policy proposals from 2002 on relations with NGOs and the private sector. We will include more on these deliberations as the week unfolds, but we encourage readers to look at the documents prepared by the WHO Secretariat available here. We also appreciated the Graduate Institute for International and Development Studies seminar on the R&D treaty proposal held earlier.